Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BridgeBio Pharma (BBIO) Tax Provisions (2024 - 2025)

Historic Tax Provisions for BridgeBio Pharma (BBIO) over the last 2 years, with Q3 2025 value amounting to -$1.5 million.

  • BridgeBio Pharma's Tax Provisions changed N/A to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, BridgeBio Pharma's Tax Provisions stood at -$1.5 million.
  • Over the past 5 years, BridgeBio Pharma's Tax Provisions peaked at $2.1 million during Q2 2025, and registered a low of -$1.5 million during Q3 2025.